AC
MURA

Armistice Capital’s Mural Oncology MURA Stock Holding History

Armistice Capital’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,722,000
Closed -$2.17M – 246
2025
Q1 		$2.17M Buy
1,722,000
+22,000
+1% +$80.2K 0.06% 145
2024
Q4 		$5.47M Hold
1,700,000
– – 0.13% 120
2024
Q3 		$5.32M Buy
1,700,000
+12,000
+0.7% +$39.1K 0.14% 122
2024
Q2 		$5.3M Buy
1,688,000
+30,000
+2% +$111K 0.14% 112
2024
Q1 		$8.11M Hold
1,658,000
– – 0.22% 106
2023
Q4 		$9.82M Buy
+1,658,000
New +$6.67M 0.26% 90

Other funds holding MURA

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $382M AUM 31.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return